title: Predatory bacteria: a potential ally against multidrug-resistant Gram-negative pathogens.
abstract: Multidrug-resistant (MDR) Gram-negative bacteria have emerged as a serious threat to human and animal health. Bdellovibrio spp. and Micavibrio spp. are Gram-negative bacteria that prey on other Gram-negative bacteria. In this study, the ability of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus to prey on MDR Gram-negative clinical strains was examined. Although the potential use of predatory bacteria to attack MDR pathogens has been suggested, the data supporting these claims is lacking. By conducting predation experiments we have established that predatory bacteria have the capacity to attack clinical strains of a variety of ß-lactamase-producing, MDR Gram-negative bacteria. Our observations indicate that predatory bacteria maintained their ability to prey on MDR bacteria regardless of their antimicrobial resistance, hence, might be used as therapeutic agents where other antimicrobial drugs fail.
authors: Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America. kadourde@umdnj.edu
authors: Daniel E
authors: DE
authors: Kadouri
authors: Kevin
authors: K
authors: To
authors: Robert M Q
authors: RM
authors: Shanks
authors: Yohei
authors: Y
authors: Doi
mesh_terms: D040981:Acinetobacter baumannii / Q000502:physiology*; D020561:Alphaproteobacteria / Q000502:physiology*; D000898:Antibiosis; D001501:Bdellovibrio / Q000502:physiology*; D052978:Disk Diffusion Antimicrobial Tests; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000502:physiology*; D007711:Klebsiella pneumoniae / Q000502:physiology*; D050296:Microbial Viability; D011549:Pseudomonas / Q000502:physiology*
references: J Appl Microbiol. 2011 Feb;110(2):431-44
references: 21114596
references: Antonie Van Leeuwenhoek. 1963;29:217-48
references: 14068454
references: J Mol Microbiol Biotechnol. 2002 Sep;4(5):467-77
references: 12432957
references: Mikrobiologiia. 1983 Sep-Oct;52(5):777-80
references: 6420651
references: Clin Infect Dis. 2012 Jul;55(2):224-31
references: 22491340
references: Mikrobiologiia. 1982 Jan-Feb;51(1):114-7
references: 7070304
references: Science. 2004 Jan 30;303(5658):689-92
references: 14752164
references: Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S51-4
references: 20929371
references: Public Health Rep. 2007 Mar-Apr;122(2):160-6
references: 17357358
references: Curr Microbiol. 2006 Feb;52(2):81-5
references: 16450066
references: Nat Rev Microbiol. 2004 Aug;2(8):669-75
references: 15263901
references: Appl Environ Microbiol. 2005 Jul;71(7):4044-51
references: 16000819
references: BMC Genomics. 2011 Sep 21;12:453
references: 21936919
references: Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1439-1452
references: 15388693
references: Appl Environ Microbiol. 2007 Jan;73(2):605-14
references: 17098913
references: Annu Rev Microbiol. 2009;63:523-39
references: 19575566
references: Antimicrob Agents Chemother. 2009 Jul;53(7):3159-61
references: 19414578
references: BMB Rep. 2012 Feb;45(2):71-8
references: 22360883
references: Antimicrob Agents Chemother. 2011 Jun;55(6):2710-3
references: 21402845
references: Int J Hyg Environ Health. 2010 Nov;213(6):428-31
references: 20850380
references: Environ Microbiol. 2006 Dec;8(12):2179-88
references: 17107559
references: Appl Environ Microbiol. 2000 Jun;66(6):2365-71
references: 10831412